Zimmer Biomet Holdings (XSWX:ZBH) Enterprise Value: CHF20,323 Mil (As of Jun. 28, 2026) ***


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
69 GF Score
Price CHF74.50
GF Value CHF100.92
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Enterprise Value?

Zimmer Biomet Holdings XSWX:ZBH +0.68% 69 Enterprise Value is CHF20,323 Mil as of Jun. 28, 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF100.92 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF956 Mil. Therefore, Zimmer Biomet Holdings's EV-to-EBIT ratio for today is 21.25.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,842 Mil. Therefore, Zimmer Biomet Holdings's EV-to-EBITDA ratio for today is 11.03.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was CHF6,713 Mil. Therefore, Zimmer Biomet Holdings's EV-to-Revenue ratio for today is 3.03.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,336 Mil. Therefore, Zimmer Biomet Holdings's EV-to-OCF ratio for today is 15.21.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,092 Mil. Therefore, Zimmer Biomet Holdings's EV-to-FCF ratio for today is 18.60.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Zimmer Biomet Holdings  (XSWX:ZBH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Zimmer Biomet Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=20323.323/956.201
=21.25

Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil.
Zimmer Biomet Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF956 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Zimmer Biomet Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=20323.323/1841.894
=11.03

Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil.
Zimmer Biomet Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,842 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Zimmer Biomet Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=20323.323/6713.439
=3.03

Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil.
Zimmer Biomet Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF6,713 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Zimmer Biomet Holdings's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=20323.323/1336.151
=15.21

Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil.
Zimmer Biomet Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,336 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Zimmer Biomet Holdings's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=20323.323/1092.407
=18.60

Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil.
Zimmer Biomet Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,092 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zimmer Biomet Holdings Enterprise Value Related Terms


Zimmer Biomet Holdings Enterprise Value Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Enterprise Value Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,948.38 27,744.10 24,783.96 26,769.77 21,458.52

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,696.20 27,283.75 19,707.29 21,458.52 19,092.40

XSWX:ZBH vs PEN, GMED, STE: Enterprise Value Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings Enterprise Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Enterprise Value falls into.


XSWX:ZBH
69GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Zimmer Biomet Holdings's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Zimmer Biomet Holdings's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of CHF20,323 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Enterprise Value of CHF20,323 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Enterprise Value too high?
Zimmer Biomet Holdings' current Enterprise Value is CHF20,323 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Enterprise Value compare to PEN and GMED?
Zimmer Biomet Holdings' Enterprise Value of CHF20,323 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Enterprise Value is CHF20,323 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF100.92, compared to a current price of CHF74.50 — trading 26.2% below its estimated fair value. The current Enterprise Value is CHF20,323 Mil. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Enterprise Value is CHF20,323 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF74.50 is trading 26.2% below its estimated GF Value™ of CHF100.92. GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.

Key valuation signals for XSWX:ZBH:

  • Enterprise Value: CHF20,323 Mil
  • GF Value™: CHF100.92 vs. price of CHF74.50 (26.2% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score

Get the complete analysis for XSWX:ZBH

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.50
Price
CHF100.92
GF Value